Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial. (Q36204500)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16038624%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

review article

1 reference

title

Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16038624%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16038624%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Ming-Liang He

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16038624%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Cheng Luo

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16038624%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Lars Bohlin

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16038624%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16038624%20AND%20SRC:MED&resulttype=core&format=json

Acta Pharmacologica Sinica

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16038624%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16038624%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16038624%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

926-933

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16038624%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1111/j.1745-7254.2005.00150.x

31 December 2019

exact match

0 references

cites work

Arthritis medicines and cardiovascular events--"house of coxibs".

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5'-flanking regulatory sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E(2), and nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3'-untranslated region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

Cellular distribution and contribution of cyclooxygenase COX-2 to diabetogenesis in NOD mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

Inhibitors of JAKs/STATs and the kinases: a possible new cluster of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

COX-3 and the mechanism of action of paracetamol/acetaminophen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

COX-2 selectivity and inflammatory processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

Immunohistochemical expression of cyclooxygenase-2 in normal kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

Cox-2 inhibitory effects of naturally occurring and modified fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2005.00150.X

10.1111/J.1745-7254.2005.00150.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16038624%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

31 December 2019

1045442107

0 references

1 reference